Neuroblastoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neuroblastoma}} | {{Neuroblastoma}} | ||
{{CMG}} | {{CMG}} {{AE}}{{HL}} | ||
==Overview== | |||
Other imaging studies for neuroblastoma include nuclear medicine studies such as fludeoxyglucose-18F positron emission tomography scan (18F-FDG PET) and metaiodobenzylguanidine (123I-MIBG) scintigraphy.<ref name="pmid19617326">{{cite journal| author=Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL| title=123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. | journal=J Nucl Med | year= 2009 | volume= 50 | issue= 8 | pages= 1237-43 | pmid=19617326 | doi=10.2967/jnumed.108.060467 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19617326 }} </ref> | |||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
===Nuclear medicine=== | |||
* Nuclear medicine studies used for diagnosis of neuroblastoma include fludeoxyglucose-18F positron emission tomography (18F-FDG PET) and metaiodobenzylguanidine (123I-MIBG) scintigraphy.<ref name="pmid19617326">{{cite journal| author=Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL| title=123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. | journal=J Nucl Med | year= 2009 | volume= 50 | issue= 8 | pages= 1237-43 | pmid=19617326 | doi=10.2967/jnumed.108.060467 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19617326 }} </ref> | |||
* 18F-FDG PET scan may distinguish stage 1 and 2 neuroblastoma from other differential diagnosis. | |||
* 123I-MIBG scintigraphy may distinguish stage 3 and 4 neuroblastoma from other differential diagnosis. | |||
* 123I-MIBG scintigraphy is superior in detecting bone marrow metastases. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 14:54, 9 October 2015
|
Neuroblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neuroblastoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Neuroblastoma other imaging findings |
|
Risk calculators and risk factors for Neuroblastoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Other imaging studies for neuroblastoma include nuclear medicine studies such as fludeoxyglucose-18F positron emission tomography scan (18F-FDG PET) and metaiodobenzylguanidine (123I-MIBG) scintigraphy.[1]
Other Imaging Findings
Nuclear medicine
- Nuclear medicine studies used for diagnosis of neuroblastoma include fludeoxyglucose-18F positron emission tomography (18F-FDG PET) and metaiodobenzylguanidine (123I-MIBG) scintigraphy.[1]
- 18F-FDG PET scan may distinguish stage 1 and 2 neuroblastoma from other differential diagnosis.
- 123I-MIBG scintigraphy may distinguish stage 3 and 4 neuroblastoma from other differential diagnosis.
- 123I-MIBG scintigraphy is superior in detecting bone marrow metastases.
References
- ↑ 1.0 1.1 Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL (2009). "123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma". J Nucl Med. 50 (8): 1237–43. doi:10.2967/jnumed.108.060467. PMID 19617326.